An international team of researchers has discovered saarvienin A, a new type of glycopeptide antibiotic. Their findings introduce a compound with strong activity against highly resistant bacterial ...

RIT biomedical engineering researchers develop new separation technique for lab-on-chip devices to distinguish cells ...

Zbiotics has sold 8m bottles of its flagship product, a shot containing bacteria that express an enzyme that breaks down alcohol in the gut.

Since launching in late 2023, Doctronic has provided 10 million quick, free and private medical consultations.

The failure is the latest stumble for a cancer drug class that hasn’t lived up to expectations. iTeos will begin a strategic ...

Absci entered its new drug into Phase I trials in half the time and for many millions of dollars less than it would have cost ...

Azafaros has secured 132 million euros ($147 million) in series B funds that the Dutch biotech will use to push its rare ...

Azafaros raises $146M Series B to advance nizubaglustat into Phase 3 trials for rare lysosomal storage disorders, with ...

Bactana Corp., a biotech startup headquartered at UConn’s Technology Incubation Program in Farmington, announced Tuesday it ...

Microorganisms generate all sorts of materials that could serve as potential agents for combating bacteria and fungi. An ...

The founder and former leader of Inhibikase Therapeutics is blazing a new biotech trail in an effort to get a beleaguered ...

A combination of the HER2 agent, called disitamab vedotin, and Junshi Biosciences’ PD-1 inhibitor toripalimab outperformed ...